Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy

Background The introduction of the prion Real-Time Quaking-Induced Conversion assay (RT-QuIC) has led to a revision of the diagnostic criteria for sporadic Creutzfeldt-Jakob disease (sCJD). Validation studies are needed for the amended criteria, especially for their diagnostic value in the clinical setting. Methods We studied 1250 patients with suspected CJD referred for diagnosis to two Italian reference centres between 2010 and 2020. Focusing on the first diagnostic assessment, we compared the diagnostic value of the old and the amended criteria and that of different combinations of clinical variables and biomarker results. Results The studied cohort comprised 850 participants with CJD (297 definite sCJD, 151 genetic CJD, 402 probable sCJD) and 400 with non-CJD (61 with neuropathology). At first clinical evaluation, the sensitivity of the old criteria (76.8%) was significantly lower than that of the amended criteria (97.8%) in the definite CJD cohort with no difference between definite and probable sCJD cases. Specificity was ~94% for both criteria against the non-CJD cohort (82.0% against definite non-CJD group). Cerebrospinal fluid (CSF) RT-QuIC was highly sensitive (93.9%) and fully specific against definite non-CJD patients. Limiting the criteria to a positive RT-QuIC or/and the combination of a clinical course compatible with possible CJD with a positive MRI (Q-CM criteria) provided higher diagnostic accuracy than both the old and amended criteria, overcoming the suboptimal specificity of ancillary test results (ie, CSF protein 14-3-3). Conclusions CSF RT-QuIC is highly sensitive and specific for diagnosing CJD in vitam. The Q-CM criteria provide a high diagnostic value for CJD.

[1]  Piero Parchi,et al.  The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases , 2022, Frontiers in Aging Neuroscience.

[2]  J. Collinge,et al.  Assessing initial MRI reports for suspected CJD patients , 2022, Journal of Neurology.

[3]  I. Zerr,et al.  Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease , 2022, JAMA network open.

[4]  B. Ghetti,et al.  Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification , 2021, Acta Neuropathologica.

[5]  I. Zerr,et al.  The importance of ongoing international surveillance for Creutzfeldt–Jakob disease , 2021, Nature Reviews Neurology.

[6]  B. Caughey,et al.  Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease , 2021, The Lancet Neurology.

[7]  S. Capellari,et al.  Diagnostic and prognostic performance of CSF α‐synuclein in prion disease in the context of rapidly progressive dementia , 2021, Alzheimer's & dementia.

[8]  L. Schonberger,et al.  Diagnosis of prion diseases by RT-QuIC results in improved surveillance , 2020, Neurology.

[9]  A. Bizzi,et al.  Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging. , 2020, JAMA neurology.

[10]  L. Sacchetto,et al.  High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD , 2020, International journal of molecular sciences.

[11]  A. Green,et al.  Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC , 2019, Journal of Neurology.

[12]  S. Capellari,et al.  Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease. , 2018, Journal of Alzheimer's disease : JAD.

[13]  W. Schulz-Schaeffer,et al.  Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance , 2018, Neurology.

[14]  M. Geschwind,et al.  Genetic PrP Prion Diseases. , 2018, Cold Spring Harbor perspectives in biology.

[15]  J. Collinge,et al.  Imaging and CSF analyses effectively distinguish CJD from its mimics , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[16]  I. Zerr,et al.  Sporadic Creutzfeldt-Jakob disease. , 2011 .

[17]  M. Geschwind,et al.  Differential diagnosis with other rapid progressive dementias in human prion diseases. , 2018, Handbook of clinical neurology.

[18]  B. Caughey,et al.  High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions , 2017, Scientific Reports.

[19]  A. Green,et al.  Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels , 2017, Acta Neuropathologica.

[20]  B. Caughey,et al.  Extended and direct evaluation of RT‐QuIC assays for Creutzfeldt‐Jakob disease diagnosis , 2016, Annals of clinical and translational neurology.

[21]  J. Ironside,et al.  Sporadic and Infectious Human Prion Diseases. , 2017, Cold Spring Harbor perspectives in medicine.

[22]  J. Neuhaus,et al.  Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease , 2015, Neurology. Clinical practice.

[23]  B. Caughey,et al.  Rapid and Sensitive RT-QuIC Detection of Human Creutzfeldt-Jakob Disease Using Cerebrospinal Fluid , 2015, mBio.

[24]  A. Bizzi,et al.  Sporadic human prion diseases: molecular insights and diagnosis , 2012, The Lancet Neurology.

[25]  I. Ferrer,et al.  Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA , 2012, Acta Neuropathologica.

[26]  R. Henry,et al.  Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias , 2011, Neurology.

[27]  Steven J Collins,et al.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion , 2011, Nature Medicine.

[28]  Brent Race,et al.  Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays , 2010, PLoS pathogens.

[29]  A. Green,et al.  The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt–Jakob disease in the UK: a 10-year review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[30]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[31]  B. Ghetti,et al.  Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification , 2009, Acta Neuropathologica.

[32]  D. Galanaud,et al.  MRI lesion profiles in sporadic Creutzfeldt–Jakob disease , 2009, Neurology.

[33]  B. Miller,et al.  Rapidly Progressive Dementia , 2016, Continuum.

[34]  H. Urbach,et al.  Pattern of Cortical Changes in Sporadic Creutzfeldt-Jakob Disease , 2007, American Journal of Neuroradiology.

[35]  A. Aguzzi,et al.  Genetic prion disease: the EUROCJD experience , 2005, Human Genetics.

[36]  B. Miller,et al.  Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. , 2005, AJNR. American journal of neuroradiology.

[37]  Y. Itoyama,et al.  Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease , 2004, Neurology.

[38]  H. Budka,et al.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.

[39]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[40]  B. Steinhoff,et al.  Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. , 1996, Archives of neurology.